Latest research indicate that the CAG-Sema compound represents a unique clinical approach for managing multiple neurodegenerative disorders . This compound, designed to modulate retinoic acid signaling, shows significant efficacy in preclinical models , notably regarding spinal muscular atrophy and related neurological conditions. Additional in… Read More